Vasoplegia syndrome is not associated with higher mortality rate after heart transplant

Acta Cardiologica Sinica

Volumn 28, Issue 2, 2012, Pages 129-136

  Kao, Chih Hong ^a   Lin, Chih Yuan ^a   Lu, Chia Wei ^a   Tsai, Yi Ting ^a   Lee, Chung Yi ^a   Lin, Yi Chang ^a   Yen, Chih Chain ^a   Tsai, Cheng Ken ^a   Yang, Hsiang Yu ^a   Tsai, Chien Sung ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Acidosis; Heart transplant; Hypotension; Vasoplegia syndrome

Indexed keywords

BICARBONATE; CREATININE;

ADULT; ARTICLE; BICARBONATE BLOOD LEVEL; BODY HEIGHT; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; HEART TRANSPLANTATION; HUMAN; MALE; PREOPERATIVE EVALUATION; PROGNOSIS; RETROSPECTIVE STUDY; SURGICAL MORTALITY; TAIWAN; VASOPLEGIA;

EID: 84865483225     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. The number of organ procurement and post-transplant survival rate based on 2006-2010 transplants. Bureau of national health insurance, department of health, executive yuan, Taiwan, ROC. (http://www.doh.gov.tw)
2. Gomes WJ, Carvalho AC, Palma JH, et al. Vasoplegic syndrome after open-heart surgery. J Cardiovasc Surg (Torino) 1998;39: 619-23.
3. Kirklin JK. Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass. Ann Thorac Surg 1991;51:529-31.
4. Wan S, Marchant A, DeSmet JM, et al. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg 1996;111:469-77. (Pubitemid 26057427)
5. Argenziano M, Chen JM, Choudhri AF, et al. Management of vasodilatory shock after cardiac surgery: identi?cation of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 1998;116:973-80. (Pubitemid 28553541)
6. Chemmalakuzhy J, Costanzo MR, Meyer P, et al. Hypotension, acidosis, and vasodilatation syndrome post-heart transplant: prognostic variables and outcomes. J Heart Lung Transplant 2001;20:1075-83. (Pubitemid 32930112)
7. Sun X, Zhang L, Hill PC, et al. Is incidence of postoperative vasoplegic syndrome different between off-pump and on-pump coronary artery bypass grafting surgery? Eur J Cardiothorac Surg 2008;34:820-5.
8. Byrne JG, Leacche M, Paul S, et al. Risk factors and outcomes for 'vasoplegia syndrome' following cardiac transplantation. Eur J Cardiothorac Surg 2004;25:327-32. (Pubitemid 38340565)
9. Lu BY, Wu HD, Wang CC, et al. The impact of length of postoperative ventilator support on outcome of the arterial switch operation - report from a single institute. Acta Cardiol Sin 2010;26:173-8.
10. Chien SJ, Chang JP, Ko SF, et al. Long-term outcome of outlet- type ventricular septal defect: focus on congestive heart failure and aortic valve disorder. Acta Cardiol Sin 2011;27:197-203.
11. Grady KL, White-Williams C, Naftel D, et al. Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality? A multi-institutional study of preoperative weight-height indices. Cardiac Transplant Research Database (CTRD). J Heart and Lung Transplant 1999;18:750-63. (Pubitemid 29424112)
12. Grady KL, Costanzo MR, Fisher S, et al. Preoperative obesity is associated with decreased survival after heart transplantation. J Heart and Lung Transplant 1996;15:863-71. (Pubitemid 26320210)
13. Mekontso-Dessap A, Houel R, Soustelle C, et al. Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg 2001;71: 1428-32.
14. Raja SG, Fida N. Should angiotensin-converting enzyme inhibitors/ angiotensin II receptor antagonists be omitted before cardiac surgery to avoid postoperative vasodilation? Interact Cardiovasc Thorac Surg 2008;7:470-5. (Pubitemid 351769090)
15. Goldstein DJ, Moazami N, Seldomridge JA, et al. Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels. Ann Thorac Surg 1997;63:971-4. (Pubitemid 27191646)
16. James KB, McCarthy PM, Thomas JD, et al. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation 1995;92:II191-5.
17. Paniagua MJ, Crespo-LeiroMG, Muñiz J, et al. Hypotension, acidosis and vasodilation syndrome after heart transplant: incidence, risk factors, and prognosis. Transplant Proc 2003;35:1957-8.
18. Carrel T, Englberger L, Mohacsi P, et al. Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance. J Card Surg 2000;15:347-53. (Pubitemid 32977031)
19. Lavigne D. Vasopressin and methylene blue: alternate therapies in vasodilatory shock. Semin Cardiothorac Vasc Anesth 2010;14: 186-9.
20. Papadopoulos G, Sintou E, Siminelakis S, et al. Perioperative infusion of low-dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting - a double-blind randomized study. J Cardiothorac Surg 2010;5:17.
21. Masetti P, Murphy SF, Kouchoukos NT. Vasopressin therapy for vasoplegic syndrome following cardiopulmonary bypass. J Card Surg 2002;17:485-9. (Pubitemid 36308361)
22. Noto A, Lentini S, Versaci A, et al. A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery. Interact Cardiovasc Thorac Surg 2009;9:588-92.
23. Evora PR, Ribeiro PJ, Vicente WV, et al. Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties. Rev Bras Cir Cardiovasc 2009;24:279-88.
24. Leite EG, Ronald A, Rodrigues AJ, et al. Is methylene blue of benefit in treating adult patients who develop catecholamineresistant vasoplegic syndrome during cardiac surgery? Interact Cardiovasc Thorac Surg 2006;5:774-8. (Pubitemid 44901245)
25. Shanmugam G. Vasoplegic syndrome -- the role of methylene blue. Eur J Cardiothorac Surg 2005;28:705-10. (Pubitemid 41539325)
26. Levin RL, Degrange MA, Bruno GF, et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg 2004;77:496-9. (Pubitemid 38186498)